A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
Clinical trial NCT06118411 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06118411
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-19
- Primary completion
- 2028-03-01
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.